Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Bioavailability of once- and twice-daily regimens of didanosine in human immunodeficiency virus-infected children.

Abreu T, Plaisance K, Rexroad V, Nogueira S, Oliveira RH, Evangelista LA, Rangel R, Silva IS, Knupp C, Lambert JS.

Antimicrob Agents Chemother. 2000 May;44(5):1375-6.

2.

Didanosine once daily: potential for expanded use.

Pollard RB.

AIDS. 2000 Nov 10;14(16):2421-8. Review.

PMID:
11101051
3.

Didanosine once daily: an overview.

Youle M.

Antivir Ther. 1998;3 Suppl 4:35-7. Review.

PMID:
10723507
4.

Pharmacology considerations for antiretroviral therapy in human immunodeficiency virus (HIV)-infected children.

Hoody DW, Fletcher CV.

Semin Pediatr Infect Dis. 2003 Oct;14(4):286-94. Review.

PMID:
14724793
5.

Didanosine enteric-coated capsule: current role in patients with HIV-1 infection.

Moreno S, Hernández B, Dronda F.

Drugs. 2007;67(10):1441-62. Review.

PMID:
17600392
6.
7.

Effect of tenofovir on didanosine absorption in patients with HIV.

Pecora Fulco P, Kirian MA.

Ann Pharmacother. 2003 Sep;37(9):1325-8. Review.

PMID:
12921517
8.

Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors.

Piliero PJ.

J Acquir Immune Defic Syndr. 2004 Sep 1;37 Suppl 1:S2-S12. Review.

PMID:
15319664
9.

[Tenofovir: pharmacology and interactions].

Azanza JR, García Quetglas E, Sádaba B, Gómez-Giu A.

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:2-6. Review. Spanish.

PMID:
19195431
10.
11.

Impact of once- and twice-daily dosing regimens on adherence and overall safety.

Hawkins T.

AIDS Read. 2004 Jun;14(6):320-2, 324, 329-31, 334-6. Review.

PMID:
15243968
12.
13.

Improving bioavailability and biodistribution of anti-HIV chemotherapy.

Giacalone G, Hillaireau H, Fattal E.

Eur J Pharm Sci. 2015 Jul 30;75:40-53. doi: 10.1016/j.ejps.2015.04.011. Review.

PMID:
25937367
14.

Blood-brain barrier properties of human immunodeficiency virus antiretrovirals.

Yazdanian M.

J Pharm Sci. 1999 Oct;88(10):950-4. Review. No abstract available.

PMID:
10514337
Items per page

Supplemental Content

Support Center